• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外、小鼠和雪貂模型中 H275Y 奥司他韦耐药甲型 H1N1pdm09 流感病毒潜在允许性神经氨酸酶突变对病毒适应性的影响。

Impact of potential permissive neuraminidase mutations on viral fitness of the H275Y oseltamivir-resistant influenza A(H1N1)pdm09 virus in vitro, in mice and in ferrets.

机构信息

Research Center in Infectious Diseases of the CHUQ-CHUL and Laval University, Québec City, QC, Canada.

出版信息

J Virol. 2014 Feb;88(3):1652-8. doi: 10.1128/JVI.02681-13. Epub 2013 Nov 20.

DOI:10.1128/JVI.02681-13
PMID:24257597
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3911590/
Abstract

Neuraminidase (NA) mutations conferring resistance to NA inhibitors (NAIs) generally compromise the fitness of influenza viruses. The only NAI-resistant virus that widely spread in the population, the A/Brisbane/59/2007 (H1N1) strain, contained permissive mutations that restored the detrimental effect caused by the H275Y change. Computational analysis predicted other permissive NA mutations for A(H1N1)pdm09 viruses. Here, we investigated the effect of T289M and N369K mutations on the viral fitness of the A(H1N1)pdm09 H275Y variant. Recombinant wild-type (WT) A(H1N1)pdm09 and the H275Y, H275Y/T289M, H275Y/N369K, and H275Y/V241I/N369K (a natural variant) NA mutants were generated by reverse genetics. Replication kinetics were performed by using ST6GalI-MDCK cells. Virulence was assessed in C57BL/6 mice, and contact transmission was evaluated in ferrets. The H275Y mutation significantly reduced viral titers during the first 12 to 36 h postinfection (p.i.) in vitro. Nevertheless, the WT and H275Y viruses induced comparable mortality rates, weight loss, and lung titers in mice. The T289M mutation eliminated the detrimental effect caused by the H275Y change in vitro while causing greater weight loss and mortality in mice, with significantly higher lung viral titers on days 3 and 6 p.i. than with the H275Y mutant. In index ferrets, the WT, H275Y, H275Y/T289M, and H275Y/V241I/N369K recombinants induced comparable fever, weight loss, and nasal wash viral titers. All tested viruses were transmitted at comparable rates in contact ferrets, with the H275Y/V241I/N369K recombinant demonstrating higher nasal wash viral titers than the H275Y mutant. Permissive mutations may enhance the fitness of A(H1N1)pdm09 H275Y viruses in vitro and in vivo. The emergence of such variants should be carefully monitored.

摘要

神经氨酸酶(NA)突变赋予对 NA 抑制剂(NAI)的耐药性,通常会损害流感病毒的适应性。唯一广泛传播的耐 NAI 病毒是 A/Brisbane/59/2007(H1N1)株,它包含允许性突变,可恢复 H275Y 变化引起的有害影响。计算分析预测了 A(H1N1)pdm09 病毒的其他允许性 NA 突变。在这里,我们研究了 T289M 和 N369K 突变对 A(H1N1)pdm09 H275Y 变异株病毒适应性的影响。通过反向遗传学生成了野生型(WT)A(H1N1)pdm09 和 H275Y、H275Y/T289M、H275Y/N369K 和 H275Y/V241I/N369K(一种天然变异)NA 突变体。通过 ST6GalI-MDCK 细胞进行复制动力学测定。在 C57BL/6 小鼠中评估毒力,在雪貂中评估接触传播。H275Y 突变在体外感染后 12 至 36 小时内显著降低病毒滴度。然而,WT 和 H275Y 病毒在小鼠中诱导了相当的死亡率、体重减轻和肺部滴度。T289M 突变消除了 H275Y 变化在体外引起的有害影响,但在小鼠中引起更大的体重减轻和死亡率,与 H275Y 突变体相比,在感染后第 3 天和第 6 天肺部病毒滴度显著更高。在指数雪貂中,WT、H275Y、H275Y/T289M 和 H275Y/V241I/N369K 重组病毒诱导了类似的发热、体重减轻和鼻洗液病毒滴度。在接触雪貂中,所有测试的病毒以相当的速度传播,H275Y/V241I/N369K 重组病毒的鼻洗液病毒滴度高于 H275Y 突变体。允许性突变可能会增强 A(H1N1)pdm09 H275Y 病毒在体外和体内的适应性。应密切监测此类变体的出现。

相似文献

1
Impact of potential permissive neuraminidase mutations on viral fitness of the H275Y oseltamivir-resistant influenza A(H1N1)pdm09 virus in vitro, in mice and in ferrets.体外、小鼠和雪貂模型中 H275Y 奥司他韦耐药甲型 H1N1pdm09 流感病毒潜在允许性神经氨酸酶突变对病毒适应性的影响。
J Virol. 2014 Feb;88(3):1652-8. doi: 10.1128/JVI.02681-13. Epub 2013 Nov 20.
2
Predicting Permissive Mutations That Improve the Fitness of A(H1N1)pdm09 Viruses Bearing the H275Y Neuraminidase Substitution.预测能够改善携带 H275Y 神经氨酸酶取代的 A(H1N1)pdm09 病毒适应性的许可性突变。
J Virol. 2022 Aug 10;96(15):e0091822. doi: 10.1128/jvi.00918-22. Epub 2022 Jul 14.
3
An I436N substitution confers resistance of influenza A(H1N1)pdm09 viruses to multiple neuraminidase inhibitors without affecting viral fitness.I436N 取代使甲型 H1N1pdm09 流感病毒对多种神经氨酸酶抑制剂产生耐药性,而不影响病毒适应性。
J Gen Virol. 2018 Mar;99(3):292-302. doi: 10.1099/jgv.0.001029.
4
Estimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant A(H1N1)pdm09 influenza viruses.评估近期耐奥司他韦的甲型H1N1pdm09流感病毒中允许性神经氨酸酶突变所带来的适应性优势。
PLoS Pathog. 2014 Apr 3;10(4):e1004065. doi: 10.1371/journal.ppat.1004065. eCollection 2014 Apr.
5
Role of permissive neuraminidase mutations in influenza A/Brisbane/59/2007-like (H1N1) viruses.允许性神经氨酸酶突变在甲型流感病毒/布里斯班/59/2007 样(H1N1)中的作用。
PLoS Pathog. 2011 Dec;7(12):e1002431. doi: 10.1371/journal.ppat.1002431. Epub 2011 Dec 8.
6
Permissive changes in the neuraminidase play a dominant role in improving the viral fitness of oseltamivir-resistant seasonal influenza A(H1N1) strains.神经氨酸酶的适应性变化在提高对奥司他韦耐药的季节性甲型H1N1流感病毒株的病毒适应性方面起主导作用。
Antiviral Res. 2015 Feb;114:57-61. doi: 10.1016/j.antiviral.2014.12.006. Epub 2014 Dec 12.
7
Impact of mutations at residue I223 of the neuraminidase protein on the resistance profile, replication level, and virulence of the 2009 pandemic influenza virus.神经氨酸酶蛋白 I223 残基突变对 2009 年大流行流感病毒耐药谱、复制水平和毒力的影响。
Antimicrob Agents Chemother. 2012 Mar;56(3):1208-14. doi: 10.1128/AAC.05994-11. Epub 2011 Dec 27.
8
Comparison of early and recent influenza A(H1N1)pdm09 isolates harboring or not the H275Y neuraminidase mutation, in vitro and in animal models.比较含有或不含有 H275Y 神经氨酸酶突变的早期和近期甲型 H1N1pdm09 分离株,在体外和动物模型中。
Antiviral Res. 2018 Nov;159:26-34. doi: 10.1016/j.antiviral.2018.09.007. Epub 2018 Sep 13.
9
The E119D neuraminidase mutation identified in a multidrug-resistant influenza A(H1N1)pdm09 isolate severely alters viral fitness in vitro and in animal models.在一株耐多药甲型H1N1pdm09流感病毒分离株中鉴定出的E119D神经氨酸酶突变,在体外和动物模型中严重改变了病毒适应性。
Antiviral Res. 2016 Aug;132:6-12. doi: 10.1016/j.antiviral.2016.05.006. Epub 2016 May 13.
10
Pandemic H1N1 2009 influenza virus with the H275Y oseltamivir resistance neuraminidase mutation shows a small compromise in enzyme activity and viral fitness.具有 H275Y 奥司他韦耐药性神经氨酸酶突变的 2009 年大流行性 H1N1 流感病毒在酶活性和病毒适应性方面略有降低。
J Antimicrob Chemother. 2011 Mar;66(3):466-70. doi: 10.1093/jac/dkq486. Epub 2010 Dec 16.

引用本文的文献

1
Evolutionary dynamics and molecular epidemiology of H1N1 pandemic 2009 influenza A viruses across swine farms in Denmark.丹麦各猪场2009年甲型H1N1大流行性流感病毒的进化动力学与分子流行病学
Virus Evol. 2025 Mar 7;11(1):veaf014. doi: 10.1093/ve/veaf014. eCollection 2025.
2
Integrated virtual screening and compound generation targeting H275Y mutation in the neuraminidase gene of oseltamivir-resistant influenza strains.针对奥司他韦耐药流感毒株神经氨酸酶基因H275Y突变的整合虚拟筛选和化合物生成
Mol Divers. 2025 Mar 14. doi: 10.1007/s11030-025-11163-0.
3
Increase of Synergistic Secondary Antiviral Mutations in the Evolution of A(H1N1)pdm09 Influenza Virus Neuraminidases.协同性次要抗病毒突变在 A(H1N1)pdm09 流感病毒神经氨酸酶进化中的增加。
Viruses. 2024 Jul 11;16(7):1109. doi: 10.3390/v16071109.
4
Impact of the H274Y Substitution on N1, N4, N5, and N8 Neuraminidase Enzymatic Properties and Expression in Reverse Genetic Influenza A Viruses.H274Y 取代对反向遗传流感 A 病毒中 N1、N4、N5 和 N8 神经氨酸酶酶学特性和表达的影响。
Viruses. 2024 Mar 1;16(3):388. doi: 10.3390/v16030388.
5
Alternative antiviral approaches to combat influenza A virus.对抗甲型流感病毒的替代抗病毒方法。
Virus Genes. 2023 Feb;59(1):25-35. doi: 10.1007/s11262-022-01935-3. Epub 2022 Oct 19.
6
Predicting Permissive Mutations That Improve the Fitness of A(H1N1)pdm09 Viruses Bearing the H275Y Neuraminidase Substitution.预测能够改善携带 H275Y 神经氨酸酶取代的 A(H1N1)pdm09 病毒适应性的许可性突变。
J Virol. 2022 Aug 10;96(15):e0091822. doi: 10.1128/jvi.00918-22. Epub 2022 Jul 14.
7
Identification of a Permissive Secondary Mutation That Restores the Enzymatic Activity of Oseltamivir Resistance Mutation H275Y.鉴定一种允许性的次要突变,该突变可恢复奥司他韦耐药突变 H275Y 的酶活性。
J Virol. 2022 Mar 23;96(6):e0198221. doi: 10.1128/jvi.01982-21. Epub 2022 Jan 19.
8
Dual oxidase 1 promotes antiviral innate immunity.双氧化酶 1 促进抗病毒先天免疫。
Proc Natl Acad Sci U S A. 2021 Jun 29;118(26). doi: 10.1073/pnas.2017130118.
9
In Vitro Characterization of Multidrug-Resistant Influenza A(H1N1)pdm09 Viruses Carrying a Dual Neuraminidase Mutation Isolated from Immunocompromised Patients.从免疫功能低下患者中分离出的携带双重神经氨酸酶突变的甲型H1N1pdm09多药耐药流感病毒的体外特性研究
Pathogens. 2020 Sep 2;9(9):725. doi: 10.3390/pathogens9090725.
10
Differential Viral-Host Immune Interactions Associated with Oseltamivir-Resistant H275Y and Wild-Type H1N1 A(pdm09) Influenza Virus Pathogenicity.与奥司他韦耐药 H275Y 和野生型 H1N1 A(pdm09) 流感病毒致病性相关的病毒-宿主免疫差异相互作用。
Viruses. 2020 Jul 24;12(8):794. doi: 10.3390/v12080794.

本文引用的文献

1
Influenza activity--United States, 2012-13 season and composition of the 2013-14 influenza vaccine.流感活动——美国,2012-13 季节和 2013-14 流感疫苗成分。
MMWR Morb Mortal Wkly Rep. 2013 Jun 14;62(23):473-9.
2
Oseltamivir-resistant influenza A(H1N1)pdm09 virus in Dutch travellers returning from Spain, August 2012.2012 年 8 月,从西班牙返回的荷兰旅行者中出现了抗奥司他韦的甲型 H1N1pdm09 流感病毒。
Euro Surveill. 2012 Sep 6;17(36):20266.
3
Recommendations for prevention and control of influenza in children, 2012-2013.2012-2013 年度儿童流感预防与控制建议
Pediatrics. 2012 Oct;130(4):780-92. doi: 10.1542/peds.2012-2308. Epub 2012 Sep 10.
4
Comparable fitness and transmissibility between oseltamivir-resistant pandemic 2009 and seasonal H1N1 influenza viruses with the H275Y neuraminidase mutation.对具有 H275Y 神经氨酸酶突变的奥司他韦耐药大流行 2009 年和季节性 H1N1 流感病毒的可比适应性和传染性。
J Virol. 2012 Oct;86(19):10558-70. doi: 10.1128/JVI.00985-12. Epub 2012 Jul 18.
5
Review of the 2011–2012 winter influenza season, northern hemisphere.北半球2011 - 2012年冬季流感季节回顾。
Wkly Epidemiol Rec. 2012 Jun 15;87(24):233-40.
6
Characteristics of a widespread community cluster of H275Y oseltamivir-resistant A(H1N1)pdm09 influenza in Australia.澳大利亚广泛社区聚集性 H275Y 奥司他韦耐药 A(H1N1)pdm09 流感的特征。
J Infect Dis. 2012 Jul 15;206(2):148-57. doi: 10.1093/infdis/jis337. Epub 2012 May 4.
7
Enhanced mammalian transmissibility of seasonal influenza A/H1N1 viruses encoding an oseltamivir-resistant neuraminidase.具有奥司他韦耐药性神经氨酸酶的季节性流感 A/H1N1 病毒增强了哺乳动物的传染性。
J Virol. 2012 Jul;86(13):7268-79. doi: 10.1128/JVI.07242-12. Epub 2012 Apr 24.
8
Oseltamivir-resistant pandemic (H1N1) 2009 virus infections, United States, 2010-11.2010-2011 年美国耐奥司他韦的大流行性(H1N1)2009 病毒感染。
Emerg Infect Dis. 2012 Feb;18(2):308-11. doi: 10.3201/eid1802.111466.
9
Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives.2009 年甲型 H1N1 流感大流行期间的抗病毒耐药性:公共卫生、实验室和临床视角。
Lancet Infect Dis. 2012 Mar;12(3):240-8. doi: 10.1016/S1473-3099(11)70318-8. Epub 2011 Dec 18.
10
Role of permissive neuraminidase mutations in influenza A/Brisbane/59/2007-like (H1N1) viruses.允许性神经氨酸酶突变在甲型流感病毒/布里斯班/59/2007 样(H1N1)中的作用。
PLoS Pathog. 2011 Dec;7(12):e1002431. doi: 10.1371/journal.ppat.1002431. Epub 2011 Dec 8.